These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23773866)

  • 61. [Characteristics of anti-Coa antibodies of the Colton blood group system and their significance in hemotherapy].
    Kuśnierz G; Bragiel I; Nowakowska E; Cwirko Z
    Acta Haematol Pol; 1983; 14(2):117-24. PubMed ID: 6673468
    [No Abstract]   [Full Text] [Related]  

  • 62. [Prevention of immunization of CCdee genotype donors with erythrocytes of ccDee genotype].
    Mikhaĭlova AA; Klimova NIa
    Gematol Transfuziol; 1984 Jun; 29(6):57-9. PubMed ID: 6432621
    [No Abstract]   [Full Text] [Related]  

  • 63. [Xg blood group system and anti-Xg(a) antibody].
    Tamaki T; Kawaguchi H; Tanaka T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():704-6. PubMed ID: 16111374
    [No Abstract]   [Full Text] [Related]  

  • 64. [Prevention of HLA-alloimmunization of recipients of platelet concentrates].
    Kuntz BM; Wollenhaupt HJ; Brüster HT
    Beitr Infusionsther; 1991; 28():209-12. PubMed ID: 1725621
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Donors' blood group declaration before donation can be used as a tool for electronic crossmatching.
    Arslan O
    Transfus Med; 2005 Dec; 15(6):487-92. PubMed ID: 16359420
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
    Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B
    N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Ok(a) antigen and anti-Ok(a) antibody].
    Okubo M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():780-1. PubMed ID: 20942188
    [No Abstract]   [Full Text] [Related]  

  • 68. Is it time to give up the crossmatch?
    Wallis JP
    J Clin Pathol; 2000 Sep; 53(9):673-5. PubMed ID: 11041056
    [No Abstract]   [Full Text] [Related]  

  • 69. Safety of the blood supply.
    Fiebig E
    Clin Orthop Relat Res; 1998 Dec; (357):6-18. PubMed ID: 9917695
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Discrepancy in ABO blood grouping.
    Khan MN; Khan TA; Ahmed Z
    J Coll Physicians Surg Pak; 2013 Aug; 23(8):590-2. PubMed ID: 23930880
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Towards universally acceptable blood.
    Clausen H; Olsson ML
    Nat Microbiol; 2019 Sep; 4(9):1426-1427. PubMed ID: 31439931
    [No Abstract]   [Full Text] [Related]  

  • 72. Brush up your medicine: blood transfusion.
    Isbister JP
    Med J Aust; 1980 May; 1(9):411-3. PubMed ID: 7393092
    [No Abstract]   [Full Text] [Related]  

  • 73. Quality control and transfusion reactions.
    Beal RW
    Anaesth Intensive Care; 1980 May; 8(2):172-7. PubMed ID: 6772054
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Directed and limited-exposure blood donations for infants and children.
    Strauss RG; Barnes A; Blanchette VS; Butch SH; Hume HA; Levy GJ; McMican A; Starling K; Mauer A
    Transfusion; 1990 Jan; 30(1):68-72. PubMed ID: 2296794
    [No Abstract]   [Full Text] [Related]  

  • 75. Predonation screening and pretransfusion testing.
    Woodfield G
    Vox Sang; 1994; 67 Suppl 5():20-7. PubMed ID: 7701821
    [No Abstract]   [Full Text] [Related]  

  • 76. [Annual Report 2004 - French National Reference Centre for Rare Blood Groups and Immunohaematology (CNRGS)].
    Rouger P; Ansart-Pirenne H; Le Pennec PY
    Transfus Clin Biol; 2005 Oct; 12(4):345-52. PubMed ID: 16153870
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Transfusional record and blood grouping methods: essential factors of transfusion safety].
    Clavier B; Trueba F; Bertin B; Descraques C; Hernandez E; Joussemet M
    Transfus Clin Biol; 2002 Oct; 9(4):265-7. PubMed ID: 12469558
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Transfusion and its specific problems in pediatrics and neonatology].
    Pérel Y; Runel C; Huguenin Y; Renesme L; Aladjidi N
    Transfus Clin Biol; 2017 Sep; 24(3):101-105. PubMed ID: 28709844
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The major factors and weak links that must be considered to achieve safety in compatability testing.
    Voak D; Knowles SM; Milkins CE; Chapman JS; Scott M
    Vox Sang; 2002 Aug; 83 Suppl 1():327-32. PubMed ID: 12617163
    [No Abstract]   [Full Text] [Related]  

  • 80. [Guidelines for electronic-data-processing-controlled serial diagnosis of donor blood samples].
    Fischer-Fröhlich CL; Stoll T; Hanfland P
    Beitr Infusionsther; 1990; 26():420-3. PubMed ID: 1703890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.